RenalSense

Indonesia
Sumbul, North Sumatra, Indonesia, 9777403

Company profile

RenalSense company profile

While prevention of kidney injury is highly dependent on early detection of potential risk, the industry has no solutions to address this need. Conventional products and protocols can only report kidney damage after it exists - not prevent it. The growing unmet need for early detection and prevention of risk and for the tools to improve the management of AKI patients in critical care have established the necessity of realtime renal diagnostics solutions. RenalSense's unique products will set new clinical gold standards, improve outcomes and reduce the cost of care.

Business identity

Contact email
[email protected]
Phone number
(617) 274-5753
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2009-01-01, Year

Headquarters

Postal code
9777403
Country code
ID
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
2
Total equity funding
$14M
Last funding
Series A / $14M / 2021-11-22
Last equity funding
Series A / $14M
Investors
2
Lead investors
2
Founders
2
Articles
12

Founders and investors

Founders

Avi KleimanMor Grinstein

Lead investors

BlueRed PartnersIsrael Innovation Authority

Investors

BlueRed PartnersIsrael Innovation Authority